Increasing evidence suggests that PD‐L1 on host immune cells, rather than tumor cells, involves in tumor immune evasion in certain cancer patients that have negative/weak PD‐L1 expression in tumors.12, 13. This evidence concerns the gene CD274 and neoplasm.